Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-23-005788

Options or other derivatives

  • CHIEF OPERATING OFFICER acquired 49,635 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Tessari Eben CHIEF OPERATING OFFICER 2023-04-01 Grant or award · Share Option +42,544 42,544 D: show line 1 in the form
Tessari Eben CHIEF OPERATING OFFICER 2023-04-01 Grant or award · Restricted Share Unit +7,091 7,091 D: show line 2 in the form
Loading xslF345X04/form4-04032023_040410.xml…